Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (161-170 of 320) with videos related to

Pageof 32
Sort By:
Clinical Endocrinology|May 19, 2017
Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancerLaura Y Wang, Jocelyn C Migliacci, R Michael Tuttle, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genesAnn M Straight, Kevin Oakley, Russell Moores, et al.
Annals of Surgical Oncology|December 25, 2013
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinomaBrian R Untch, Frank L Palmer, Ian Ganly, et al.
Diabetes Care|December 28, 2017
No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER TrialLaszlo Hegedüs, Steven I Sherman, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|September 24, 2014
Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillanceRalph P Tufano, Gary Clayman, Keith S Heller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawalR Michael Tuttle, Matvey Brokhin, Gal Omry, et al.
Thyroid : Official Journal of the American Thyroid Association|December 20, 2002
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude miceAndrew J Bauer, Richard Terrell, Nalinikrishna K Doniparthi, et al.
European Journal of Endocrinology|August 25, 2023
Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensusLuca Giovanella, Federica D'Aurizio, Alicia Algeciras-Schimnich, et al.
The Laryngoscope|April 21, 2015
RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification systemRebecca Zeuren, Agnese Biagini, Ravinder K Grewal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2009
Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablationRavinder K Grewal, Steven M Larson, Christina E Pentlow, et al.
Pageof 32

Showing results (161-170 of 320) with videos related to

Sort By:
Pageof 32
Clinical Endocrinology|May 19, 2017
Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancerLaura Y Wang, Jocelyn C Migliacci, R Michael Tuttle, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genesAnn M Straight, Kevin Oakley, Russell Moores, et al.
Annals of Surgical Oncology|December 25, 2013
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinomaBrian R Untch, Frank L Palmer, Ian Ganly, et al.
Diabetes Care|December 28, 2017
No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER TrialLaszlo Hegedüs, Steven I Sherman, R Michael Tuttle, et al.
Thyroid : Official Journal of the American Thyroid Association|September 24, 2014
Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillanceRalph P Tufano, Gary Clayman, Keith S Heller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawalR Michael Tuttle, Matvey Brokhin, Gal Omry, et al.
Thyroid : Official Journal of the American Thyroid Association|December 20, 2002
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude miceAndrew J Bauer, Richard Terrell, Nalinikrishna K Doniparthi, et al.
European Journal of Endocrinology|August 25, 2023
Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensusLuca Giovanella, Federica D'Aurizio, Alicia Algeciras-Schimnich, et al.
The Laryngoscope|April 21, 2015
RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification systemRebecca Zeuren, Agnese Biagini, Ravinder K Grewal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 2009
Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablationRavinder K Grewal, Steven M Larson, Christina E Pentlow, et al.
Pageof 32